Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:3840 |
Name | craniopharyngioma |
Definition | |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation benign neoplasm organ system benign neoplasm nervous system benign neoplasm central nervous system benign neoplasm craniopharyngioma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|---|---|---|---|
BRAF V600E | Dabrafenib + Trametinib | craniopharyngioma | predicted - sensitive | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01964300 | Phase II | Peginterferon alfa-2b | Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery | Terminated | USA | 0 |
NCT05465174 | Phase II | Nivolumab + Tovorafenib Tovorafenib Nivolumab | Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults (PNOC029) | Recruiting | USA | 0 |
NCT05525273 | Phase II | Dabrafenib + Trametinib | Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma (Swecranio) | Recruiting | SWE | 0 |